JPRN-UMIN000027161
Recruiting
Phase 3
TOPICal Steroid versus placebo for the prevention of radiation dermatitis in head and neck cancer patients receiving chemoradiotherapy : a phase III, randomized, double-blinded trial - TOPICS study(J-SUPPORT 1602)
Department of Radiation Oncology, National Cancer Center Hospital East0 sites220 target enrollmentMay 1, 2017
Overview
- Phase
- Phase 3
- Intervention
- Not specified
- Conditions
- ocally Advanced Squamous Cell Carcinoma of the Head and Heck
- Sponsor
- Department of Radiation Oncology, National Cancer Center Hospital East
- Enrollment
- 220
- Status
- Recruiting
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- •Received steroid therapy before this treatment Have an infection Have allergies to Vaseline or topical steroid Have severe complications
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Not Applicable
Double blind placebo controlled trial of steroids in Bacterial MeningitisISRCTN42986828niversity of Oxford (UK)
Completed
Not Applicable
Safety and pharmacodynamics of KB002, an anti granulocyte monocyte colony stimulating factor (GM-CSF) monoclonal antibody, in patients with persistent symptomatic asthmaPersistent symptomatic asthmaRespiratory - AsthmaACTRN12607000554460Kalobios Pharmaceuticals Inc.24
Completed
Not Applicable
Placebo-controlled trial to compare the inhibitory and protective efficacy of epinastine hydrochloride on nasal symptoms, using a nasal provocation test with orchard grass pollen antigen disc in orchard grass pollinosis.Orchard grass pollinosisJPRN-UMIN000002721ippon Medical School16
Not yet recruiting
Phase 1
Randomized and placebo-controlled clinical Study of Bushen Tiaoyuan Tongluo Formula in Combination with PD-1 Inhibitor and Chemotherapy for Advanced Non-small Cell Lung CancerITMCTR2000003240Shanghai Pulmonary Hospital
Completed
Phase 1
A Phase 1 study to evaluate Safety, Tolerability and Pharmacokinetics of LMR-123 in Healthy SubjectsAcute Ischemic StrokeStroke - IschaemicACTRN12619001609145Australia Medical Industries Pty Ltd.52